The impact of maternal anti-retroviral therapy on cytokine profile in the uninfected neonates

Human Immunology

Volumn 74, Issue 9, 2013, Pages 1051-1056

  Kasahara, Taissa M ^a   Hygino, Joana ^a   Blanco, Bernardo ^a   Xavier, Luciana ^a   Araújo Lima, Carlos Fernando ^a   Guillermo, Landi V C ^a   Bittencourt, Vera Carolina B ^a   Guimarães, Vander ^b   Andrade, Arnaldo F B ^c   Bento, Cleonice A M ^a  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NEWBORN; POLYCLONAL ACTIVATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY WEIGHT; CELLS, CULTURED; CYTOKINES; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84880932222     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.06.010     Document Type: Article

References (29)

1. De Cock K.M., Fowler M.G., Mercier E., et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000, 283(9):1175-1182.
2. Garcia P.M., Kalish L.A., Pitt J., et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and infants transmission study group. N Engl J Med 1999, 341(6):394-402.
3. Mofenson L.M., Lambert J.S., Stiehm E.R., et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS clinical trials group study 185 team. N Engl J Med 1999, 341(6):385-393.
4. Sperling R.S., Shapiro D.E., Coombs R.W., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med 1996, 335(22):1621-1629.
5. World Health Organization. HIV/AIDS Programme. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendation for a public helath approach. 2010.
6. Dryden-Peterson S., Shapiro R.L., Hughes M.D., et al. Increased risk of severe infant anemia following exposure to maternal HAART, botswana. J Acquir Immune Defic Syndr 2011, 56(5):428-443.
7. Bunders M.J., Bekker V., Scherpbier H.J., et al. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 2005, 94(11):1571-1577.
8. Bunders M., Thorne C., Newell M.L. European collaborative study. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-infected mothers. AIDS 2005, 19(10):1071-1079.
9. Strunk T., Burgner D. Genetic susceptibility to neonatal infection. Curr Opin Infect Dis 2006, 19:259-263.
10. Lewis D.B., Gern J.E., Hill H.R., et al. Newborn immunology: relevance to the clinician. Curr Probl Pediatr Adolesc Health Care 2006, 36:189-204.
11. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006, 118:137-144.
12. Ono E., Nunes dos Santos A.M., Menezes Succi R.C., et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Boil Res 2008, 41:700-708.
13. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy?. Semin Immunopathol 2007, 29:95-113.
14. Saito S., Shiozaki A., Sasak Y., et al. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol 2007, 29:115-122.
15. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 5:266-271.
16. Piccini P.M. T cells in normal pregnancy and recurrent pregnancy loss. Reprod Biomed 2006, 13:840-844.
17. Wilczynski J.R. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia-the same basic mechanism?. Hum Immunol 2006, 67:492-511.
18. + regulatory T cells in early pregnancy subjects and spontaneous abortion. Mol Hum Reprod 2004, 10:347-353.
19. Huppertz B. The feto-maternal interface: setting the stage for potential immune interactions. Semin Immunopathol 2007, 29:83-94.
20. Shimada S., Nishida R., Takeda M., et al. Natural killer, natural killer T, helper and cytotoxic T cells in the deciduas from sporadic miscarriage. Am J Reprod Immunol 2006, 56:193-200.
21. Fiore S., Newell M.L., Trabattoni D., et al. Antitiretroviral therapy-associated modulation of Th1 and Th2 immune response in HIV-infected pregnant women. J Reprod Immunol 2006, 70:143-150.
22. Jordan J.A., Huff D., Deloia J.A. Placental cellular immune response in women infected with human parvovirus b19 during pregnancy. Clin Diag Lab Immunol 2001, 8:288-292.
23. Disease B.B. Outcomes as a consequence of environmental influences on the development of the immune system. Curr Opin Allergy Clin Immunol 2007, 9:185-189.
24. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010, 63(6):425-433.
25. Romero R., Gotsch F., Pineles B., et al. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007, 65:S194-S202.
26. Madsen-Bouterse S.A., Romero R., Tarca A.L., et al. The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 2010, 63:73-92.
27. Cardenas I., Aldo P., Koga K., et al. Subclinical viral infection in pregnancy lead to inflammatory process at the placenta with non-lethal fetal damage. Am J Reprod Immunol 2009, 61:397.
28. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
29. Powis K.M., Smeaton L., Ogwu A., et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr 2011, 56(2):131-138.